CeleCor Therapeutics, Inc.

New Filing
CIK: 0001705381·Biotechnology·DELAWARE·Filed: May 10, 2021
Total Offering

$5,000,000

Amount Sold

$1,000,000

Investors

1

First Sale

May 3, 2021

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2017
Non-Accredited Investors
No

Related Persons

NameRole
Robert Hillman
Related Person
Peter B. Finn
Related Person
Andreas Ritzi
Related Person
Jack Lief
Related Person

Company

CeleCor Therapeutics, Inc.

1155 CAMINO DEL MAR

DEL MAR, CA, 92014

858-777-9750

SEC Filing

0001705381-21-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free